Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

217 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-09-09

Study Completion Date

2025-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this research is assess imaging and identification of soft plaque that undergoes large deformations or strain will identify plaque vulnerable to rupture which could lead to 'silent strokes'. Validation of current study results with MRI will foster use of real-time ultrasound (US) strain imaging and strain indices as a screening tool for identifying normal human participants susceptible to increased vascular aging and developing plaque prone to rupture or micro-embolization.

Current research will evaluate Lagrangian carotid strain imaging (LCSI) for prediction of vascular health on volunteers. In this study, investigators will evaluate age-related strain variations (due to plaque deposition) in the carotid artery, establishing groundwork that will help identify typical and atypical values for these indices. Investigator's hypothesis is that plaques with higher strain indices (softer plaques) are more prone to rupture than plaques with lower strain indices (stiffer) plaques, thus requiring intervention. Clinical criteria for treatment has focused primarily on the degree of stenosis. Long-term objectives are to provide non-invasive methods for screening participants at risk for vascular aging or plaque rupture in asymptomatic participants, expanding upon current criteria for risk assessments based on focal transient ischemic attack (TIA) or strokes. Variations in vessel strain have been associated with, or are precursors to, plaque deposition, vascular aging, or cerebrovascular diseases. Increased arterial strain and pressure changes have been linked to brain aging using magnetic resonance imaging (MRI) based vascular indices, and memory deficits commonly linked to Alzheimer dementia. Stiffening and thickening of the arterial walls have also been associated with cerebrovascular disease. Investigators hypothesize that strain indices as vascular biomarkers can be utilized for screening possible 'vulnerable participants' validated with MRI, with the potential ability to improve endothelial function and reverse vascular aging. Strain indices may enable differentiating study participants with vascular cognitive impairment (VCI) from other dementias. Cognitive testing is unable to make this differentiation.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

3D Multi-Contrast Atherosclerosis Characterization of the Carotid Artery

NCT02163408

Carotid Artery Disease

COMPLETED

MRI Biomarkers and Exercise

NCT02729428

Cerebrovascular Circulation

COMPLETED

Prospective Evaluation of the Biomechanical Properties of the Thoracic Aorta Coupling Magnetic Resonance Imaging and In-vitro Elasticity Tests in Patients With Ascending Aortic Aneurysm

NCT03746964

Patient With Ascending Aortic Aneurysm With Surgical Indication for Replacement

RECRUITING

Implementation of Non-size Markers Derived From 4D Flow MRI of Patients With Aortic Disease.

NCT02467062

Aortic Valve Disease Aortic Aneurysm

COMPLETED NA

Technical Development of Cardiovascular Magnetic Resonance Imaging

NCT00064896

Peripheral Artery Disease

COMPLETED PHASE1

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy Carotid Artery Diseases

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Aim 1: Ultrasound Only

Approximately 280 asymptomatic participants will participate in ultrasound (US) studies and blood work.

Ultrasound imaging

Intervention Type DEVICE

Carotid artery ultrasound exam. US imaging will include complete clinical carotid ultrasound examination (B-mode, Doppler and color-flow modes), clinical strain and shear wave imaging study, backscattered and beam-steered radiofrequency (RF) data acquisition using research mode, and reference phantom RF data acquisition.

Aim 2: Ultrasound and MRI

A sub-group of 40 at risk volunteers determined from the clinical ultrasound scans and bloodwork from Aim 1 will be asked to participate in a longitudinal US and MRI study. Participants will be selected from a population of individuals that do not have significant atherosclerosis, but present with increased risk due to the presence of soft, lipid rich plaque that are hypoechogenic or echolucent on ultrasound B-mode images. These participants may also satisfy the current clinical guidelines of increased vessel diameter and decreased blood flow velocity with ultrasound that may result in plaque deposition for being in the at risk population. Participants will receive US, strain and shear wave imaging every 2 years after the first scan in Aim 1 and MRI Imaging in Year 1 and Year 5: separated by 4 years

Ultrasound imaging

Intervention Type DEVICE

Carotid artery ultrasound exam. US imaging will include complete clinical carotid ultrasound examination (B-mode, Doppler and color-flow modes), clinical strain and shear wave imaging study, backscattered and beam-steered radiofrequency (RF) data acquisition using research mode, and reference phantom RF data acquisition.

Magnetic Resonance Imaging (MRI)

Intervention Type DEVICE

Head and Neck MRI exam with contrast

Neurocognitive testing

Intervention Type OTHER

Harmonization battery to assess executive function/attention, speeded psychomotor, verbal, and nonverbal memory, language, and visuospatial skills

Transcranial Doppler (TCD)

Intervention Type DEVICE

Use of a TCD system to monitor right and left middle cerebral artery Doppler waveforms in the volunteer for 60 minutes

Pulse Wave Doppler

Intervention Type DEVICE

Pulse wave Doppler will be used to acquire a Doppler waveform in the right common carotid artery and the right femoral artery

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Ultrasound imaging

Carotid artery ultrasound exam. US imaging will include complete clinical carotid ultrasound examination (B-mode, Doppler and color-flow modes), clinical strain and shear wave imaging study, backscattered and beam-steered radiofrequency (RF) data acquisition using research mode, and reference phantom RF data acquisition.

Intervention Type DEVICE

Magnetic Resonance Imaging (MRI)

Head and Neck MRI exam with contrast

Intervention Type DEVICE

Neurocognitive testing

Harmonization battery to assess executive function/attention, speeded psychomotor, verbal, and nonverbal memory, language, and visuospatial skills

Intervention Type OTHER

Transcranial Doppler (TCD)

Use of a TCD system to monitor right and left middle cerebral artery Doppler waveforms in the volunteer for 60 minutes

Intervention Type DEVICE

Pulse Wave Doppler

Pulse wave Doppler will be used to acquire a Doppler waveform in the right common carotid artery and the right femoral artery

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Aim 1 (Ultrasound (US) only):

* Adults at least 18 years
* Are able to provide written informed consent on their own behalf

Aim 2 (US and MRI):

* Participation in the US study (Aim 1)
* Determined by presence of hypoechogenic or echolucent lipid-rich soft plaque during initial ultrasound imaging session
* Adults willing to participate over 5 years

Exclusion Criteria

Aim 1 (US only)

* Women that are currently pregnant
* Inability to cooperate with the ultrasound study, in particular those unable to sit without gross movement for the duration the ultrasound study (estimated at 60-90 minutes)
* Open wounds or sores in the anterior neck
* History of cancer treatment, vascular disease, cardiac disease, stroke or TIA
* History of medications that affect vascular wall and plaque
* History of statin medications\*
* History of hypertension medications\*
* History of anticoagulation, blood thinners

* These criteria will not be exclusionary for the cohort that is greater than 70 years of age.

Aim 2 (US and MRI):

* Women that are currently pregnant
* Inability to cooperate with the ultrasound study, in particular those unable to sit without gross movement for the duration the ultrasound study (estimated at 60-90 minutes)
* Patients that require intravenous (IV) conscious sedation for imaging are not eligible; patients requiring mild, oral anxiolytics for research imaging will be allowed to participate as long as the following criteria are met:
* The participant has their own prescription for the medication;
* The informed consent process is conducted prior to the self-administration of this medication; and,
* The participant comes to the research visit with a driver
* Contraindications to MR
* Unable to lie in the MRI scanner for 45-60 minutes
* Patients with a contraindication to gadolinium based contrast agents, including allergy or impaired renal function (per University of Wisconsin Health Guidelines)

Minimum Eligible Age

18 Years

Maximum Eligible Age

89 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes